Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Agilent Technologies logo — Let’s Bring Great Science to Life.

Agilent Technologies

Let’s Bring Great Science to Life.

Founded 1999 United States Santa Clara, United States 18344 employees IPO Total: $2.60B Biotechnology, Health Care +2

General Information

Company Name Agilent Technologies
Founded Year 1999
Location United States Santa Clara, United States
Employees 18344
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage IPO
Business Model B2B, D2C, SaaS
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Agilent Technologies. To contact Agilent Technologies, visit agilent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Agilent Technologies compare?

A PDF of Agilent Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Agilent Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Nov 06, 2026

Agilent Technologies partnered with Columbia University to open the Agilent Innovation Hub for Cancer Research.

Acquisition Made Nov 04, 2026

Agilent Technologies has acquired Proscia, a digital-pathology software provider, to strengthen its pathology portfolio.

Product Launch Nov 03, 2026

Agilent Technologies introduced the new CE-IVD-marked Agilent TapeStationDx portfolio for clinical NGS testing workflows.

Agilent Technologies a competitor of yours? Have our desk watch it

About Agilent Technologies

Agilent Technologies is positioned as a leader in the intersection of biotechnology, health care, life sciences, and pharmaceutical industries. Founded in 1999, this United States-based company is dedicated to transforming scientific endeavors into tangible solutions that impact global health and environmental sustainability.

Their slogan, "Let’s Bring Great Science to Life," encapsulates their mission. Agilent provides a comprehensive suite of advanced analytical, research, and diagnostic tools. Their offerings cater to sectors ranging from cancer treatment to alternative energy solutions. A key differentiator is Agilent’s CrossLab and technical teams, whose expertise enables clients to optimize laboratory operations, thereby enhancing focus on scientific advancements.

Financially solid, Agilent Technologies reported 2022 fiscal revenue of US $6.85 billion. Their latest financing round was a $500.00M Post IPO Debt investment in September 2019, underscoring continued investor confidence.

Business keywords: Cancer Treatment, Food Safety, Water Quality, Air Quality, Medicine Quality, Drug Discovery, Infectious Disease Research, Alternative Energy, Analytical Solutions, Diagnostic Solutions, Laboratory Optimization, Clinical Diagnostics, Genomics, Pathology, Biopharma

Services & Products

Digital solutions for lab transformation
Genomic DNA analysis
Hydrogen fuel purity testing
PFAS sample preparation
Software & Informatics
Maintenance and repair services
Training and webinars

Target Customers

Pathology labs Research laboratories Biochemie Lab Operations Managers Scientists in genomics and semiconductor industries Agilent community members

Pricing

as listed on Nov 6, 2026

On request

Agilent Technologies's pricing page

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $500.00M -
01 Sep 2019
Grant €190.00K -
01 Mar 2010
Seed £750.00K -
01 Aug 2008
IPO $2.10B -
01 Nov 1999
Corporate Spinout Undisclosed 1
HP
01 Jan 1999

Latest News

View All
Agilent Technologies (A), What Is Drawing Fresh Attention To The Stock? — Simply Wall St
Agilent Technologies (A), What Is Drawing Fresh Attention To The Stock?
Simply Wall St Nov 07, 2026
Proscia Joins Agilent in $240 Million Pathology Software Deal — MyChesCo
Proscia Joins Agilent in $240 Million Pathology Software Deal
MyChesCo Nov 06, 2026

Agilent Technologies Alternatives & Competitors

View All Alternatives
Agilent Technologies vs
ATCG India
ATCG India India

Smarter solutions for Life Science

24 employees
Biotechnology, Health Care
Compare Agilent Technologies vs ATCG India
Agilent Technologies vs
Quantigen Biosciences
Quantigen Biosciences United States

Biosciences

32 employees
Biotechnology, Health Care
Compare Agilent Technologies vs Quantigen Biosciences
Agilent Technologies vs
Anagnostics
Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs i...

Venture round
Biotechnology, Health Care
View all alternatives

FAQ About Agilent Technologies

Let’s Bring Great Science to Life.
Agilent Technologies was founded in 1999.
Agilent Technologies is headquartered in Santa Clara, United States.
Agilent Technologies operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on Cancer Treatment, Food Safety, Water Quality and Air Quality. Its customers include Pathology labs, Research laboratories and Biochemie Lab Operations Managers.
Agilent Technologies has a B2B, D2C and SaaS business model. Its revenue comes from Product Sales, Service Fee and Subscription.
As listed on Agilent Technologies's pricing page on Nov 6, 2026: On request.
Agilent Technologies has approximately 18344 employees.
Agilent Technologies has completed 5 funding rounds, raising a total of $2.60B. The latest funding stage is IPO.
Agilent Technologies offers: Digital solutions for lab transformation, Genomic DNA analysis, Hydrogen fuel purity testing, PFAS sample preparation, Software & Informatics, Maintenance and repair services, Training and webinars.
Top alternatives and competitors to Agilent Technologies include ATCG India, Quantigen Biosciences, Anagnostics, Drug Discovery & Development, PathAI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Agilent Technologies and ATCG India are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Agilent Technologies, https://bouncewatch.com/company/agilent-technologies, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout